Literature DB >> 28435536

Norbenzomorphan Scaffold: Chemical Tool for Modulating Sigma Receptor-Subtype Selectivity.

James J Sahn1, Timothy R Hodges1, Jessica Z Chan1, Stephen F Martin1.   

Abstract

Some norbenzomorphans exhibit high affinity for sigma 1 and sigma 2 receptors, and varying the position of substituents on the aromatic ring of this scaffold has a significant effect on subtype selectivity. In particular, compounds bearing several different substituents at C7 of the norbenzomorphan ring system exhibit a general preference for the sigma 1 receptor, whereas the corresponding C8-substituted analogues preferentially bind at the sigma 2 receptor. These findings suggest that the norbenzomorphan scaffold may be a unique chemical template that can be easily tuned to prepare small molecules for use as tool compounds to study the specific biological effects arising from preferential binding at either sigma receptor subtype. In the absence of structural characterization data for the sigma 2 receptor, such compounds will be useful toward refining the pharmacophore model of its binding site.

Entities:  

Keywords:  Alzheimer’s disease; Sigma receptor; neuroprotection; norbenzomorphan; traumatic brain injury

Year:  2017        PMID: 28435536      PMCID: PMC5392765          DOI: 10.1021/acsmedchemlett.7b00066

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  36 in total

1.  Facile and unified approach to skeletally diverse, privileged scaffolds.

Authors:  James J Sahn; Justin Y Su; Stephen F Martin
Journal:  Org Lett       Date:  2011-04-22       Impact factor: 6.005

Review 2.  Early development of sigma-receptor ligands.

Authors:  Sanju Narayanan; Rohit Bhat; Christophe Mesangeau; Jacques H Poupaert; Christopher R McCurdy
Journal:  Future Med Chem       Date:  2011-01       Impact factor: 3.808

3.  Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease.

Authors:  Bitna Yi; James J Sahn; Pooneh Memar Ardestani; Andrew K Evans; Luisa L Scott; Jessica Z Chan; Sangeetha Iyer; Ashley Crisp; Gabriella Zuniga; Jonathan T Pierce; Stephen F Martin; Mehrdad Shamloo
Journal:  J Neurochem       Date:  2017-02       Impact factor: 5.372

4.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

5.  Development of Novel Alkoxyisoxazoles as Sigma-1 Receptor Antagonists with Antinociceptive Efficacy.

Authors:  Hao Sun; Min Shi; Wei Zhang; Yue-Ming Zheng; Ya-Zhou Xu; Jun-Jie Shi; Ting Liu; Hendra Gunosewoyo; Tao Pang; Zhao-Bing Gao; Fan Yang; Jie Tang; Li-Fang Yu
Journal:  J Med Chem       Date:  2016-06-30       Impact factor: 7.446

6.  Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain.

Authors:  N Narita; K Hashimoto; S Tomitaka; Y Minabe
Journal:  Eur J Pharmacol       Date:  1996-06-20       Impact factor: 4.432

7.  Syntheses and anticholinesterase activity of tetrahydrobenzazepine carbamates.

Authors:  Y L Chen; D Liston; J Nielsen; D Chapin; A Dunaiskis; K Hedberg; J Ives; J Johnson; S Jones
Journal:  J Med Chem       Date:  1994-06-24       Impact factor: 7.446

Review 8.  The σ2 receptor: a novel protein for the imaging and treatment of cancer.

Authors:  Robert H Mach; Chenbo Zeng; William G Hawkins
Journal:  J Med Chem       Date:  2013-06-18       Impact factor: 7.446

9.  Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site.

Authors:  Jinbin Xu; Chenbo Zeng; Wenhua Chu; Fenghui Pan; Justin M Rothfuss; Fanjie Zhang; Zhude Tu; Dong Zhou; Dexing Zeng; Suwanna Vangveravong; Fabian Johnston; Dirk Spitzer; Katherine C Chang; Richard S Hotchkiss; William G Hawkins; Kenneth T Wheeler; Robert H Mach
Journal:  Nat Commun       Date:  2011-07-05       Impact factor: 14.919

10.  The Sigma-2 Receptor and Progesterone Receptor Membrane Component 1 are Different Binding Sites Derived From Independent Genes.

Authors:  Uyen B Chu; Timur A Mavlyutov; Ming-Liang Chu; Huan Yang; Amanda Schulman; Christophe Mesangeau; Christopher R McCurdy; Lian-Wang Guo; Arnold E Ruoho
Journal:  EBioMedicine       Date:  2015-10-19       Impact factor: 8.143

View more
  10 in total

1.  Natural Products and Their Mimics as Targets of Opportunity for Discovery.

Authors:  Stephen F Martin
Journal:  J Org Chem       Date:  2017-09-15       Impact factor: 4.354

2.  High-Content Microfluidic Screening Platform Used To Identify σ2R/Tmem97 Binding Ligands that Reduce Age-Dependent Neurodegeneration in C. elegans SC_APP Model.

Authors:  Sudip Mondal; Evan Hegarty; James J Sahn; Luisa L Scott; Sertan Kutal Gökçe; Chris Martin; Navid Ghorashian; Praveen Navoda Satarasinghe; Sangeetha Iyer; Wisath Sae-Lee; Timothy R Hodges; Jonathan T Pierce; Stephen F Martin; Adela Ben-Yakar
Journal:  ACS Chem Neurosci       Date:  2018-02-23       Impact factor: 4.418

3.  Small molecule modulators of σ2R/Tmem97 reduce alcohol withdrawal-induced behaviors.

Authors:  Luisa L Scott; James J Sahn; Antonio Ferragud; Rachel C Yen; Praveen N Satarasinghe; Michael D Wood; Timothy R Hodges; Ted Shi; Brooke A Prakash; Kaitlyn M Friese; Angela Shen; Valentina Sabino; Jonathan T Pierce; Stephen F Martin
Journal:  Neuropsychopharmacology       Date:  2018-04-20       Impact factor: 7.853

4.  Neuroprotective Efficacy of a Sigma 2 Receptor/TMEM97 Modulator (DKR-1677) after Traumatic Brain Injury.

Authors:  Edwin Vázquez-Rosa; Michael R Watson; James J Sahn; Timothy R Hodges; Rachel E Schroeder; Coral J Cintrón-Pérez; Min-Kyoo Shin; Terry C Yin; Josie L Emery; Stephen F Martin; Daniel J Liebl; Andrew A Pieper
Journal:  ACS Chem Neurosci       Date:  2018-12-03       Impact factor: 4.418

5.  Development of Tetrahydroindazole-Based Potent and Selective Sigma-2 Receptor Ligands.

Authors:  Iredia D Iyamu; Wei Lv; Neha Malik; Rama K Mishra; Gary E Schiltz
Journal:  ChemMedChem       Date:  2019-06-03       Impact factor: 3.466

6.  Identification of the gene that codes for the σ2 receptor.

Authors:  Assaf Alon; Hayden R Schmidt; Michael D Wood; James J Sahn; Stephen F Martin; Andrew C Kruse
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-30       Impact factor: 11.205

7.  Discovery of a novel class of potent and selective tetrahydroindazole-based sigma-1 receptor ligands.

Authors:  Iredia D Iyamu; Wei Lv; Neha Malik; Rama K Mishra; Gary E Schiltz
Journal:  Bioorg Med Chem       Date:  2019-03-16       Impact factor: 3.641

8.  Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice.

Authors:  James J Sahn; Galo L Mejia; Pradipta R Ray; Stephen F Martin; Theodore J Price
Journal:  ACS Chem Neurosci       Date:  2017-07-13       Impact factor: 4.418

9.  Neuroprotective Effects of σ2R/TMEM97 Receptor Modulators in the Neuronal Model of Huntington's Disease.

Authors:  Jing Jin; Nicolas Arbez; James J Sahn; Yan Lu; Kathryn T Linkens; Timothy R Hodges; Anthony Tang; Robyn Wiseman; Stephen F Martin; Christopher A Ross
Journal:  ACS Chem Neurosci       Date:  2022-09-15       Impact factor: 5.780

10.  Identification and characterization of MAM03055A: A novel bivalent sigma-2 receptor/TMEM97 ligand with cytotoxic activity.

Authors:  Cheri Z Liu; Marco Mottinelli; Hilary E Nicholson; Bridget M McVeigh; Neelum K Wong; Christopher R McCurdy; Wayne D Bowen
Journal:  Eur J Pharmacol       Date:  2021-06-16       Impact factor: 5.195

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.